Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-001607

Director acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SAXE JON S Director 2021-03-19 Option exercise +2,500 $1.50 $3,750 5,751 D
Derivatives
SAXE JON S Director 2021-03-19 Option exercise · Stock Option (Right to Buy) −2,500 0 D
Loading xslF345X03/form4-03222021_040300.xml…